Powered by
Sponsored by

Baba Ramdev's Patanjali says Coronil is the first evidence-based medicine to fight COVID-19

Coronil can now be exported to 158 countries

PTI02_19_2021_000116B Baba Ramdev releases the scientific research papers on the Patanjali medicine for COVID-19, during a press conference in New Delhi, on Friday | PTI

Haridwar-based Patanjali Ayurved, on Friday, said Coronil has now received certification from Ayush Ministry as per World Health Organisation (WHO) certification scheme.

The company claimed that it is the first evidence-based medicine to fight COVID-19.

The medicine was launched in New Delhi at an event which was presided by Union Health Minister Harsh Vardhan and Transport Minister Nitin Gadkari.

"Coronil has received the Certificate of Pharmaceutical Product (CoPP) from the Ayush section of Central Drugs Standard Control Organisation as per the WHO certification scheme," said Patanjali in a statement.

Under CoPP, Coronil can now be exported to 158 countries.

Commenting of the development Yoga gudur Ramdev said, Coronil will help the humanity while providing affordable treatment based on naturopathy.

On the basis of presented data, the Ministry of Ayush has recognised Coronil Tablet as a medicine for "supporting measure in COVID-19."

Patanjali had earlier introduced Ayurveda-based Coronil on June 23 last year, when the pandemic was at its peak.

However, it had to face severe criticism as it lacked scientific evidence.

Then, the Ayush Ministry had indicated it as "Immuno-booster" only.

Coronil is developed by Patanjali Research Institute. It had started work for an Ayurvedic remedy for COVID-19 in January, 2020.

📣 The Week is now on Telegram. Click here to join our channel (@TheWeekmagazine) and stay updated with the latest headlines